SCHEMBL5771081

SCHEMBL5771081

COC(C)(OC)c1ccn2ccnc2n1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 4/20 0.34
GAA P10253 4/20 0.34
NPC1 O15118 4/20 0.34
RAB9A P51151 4/20 0.34
SMN1; SMN2 Q16637 4/20 0.34
GLA P06280 3/20 0.34
POLB P06746 1/20 0.34
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
HPGD P15428 3/20 0.30
DYRK1A Q13627 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5770463 0.84 ALDH1A1 (0.36) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL5769993 0.81 GABRA1 (0.39) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL5768555 0.81 GABRA1 (0.33) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL6217363 0.79 PLCG1 (0.38) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL6218809 0.77 HMGCR (0.32) NPC1RAB9AGABRA1GABRG2GABRB3
SCHEMBL5770695 0.77 JAK2 (0.36)
SCHEMBL7225919 0.73 KDM4E (0.40) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL6102107 0.70 ALDH1A1 (0.39) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL6217690 0.69 HPGD (0.41) KDM4EALDH1A1GAANPC1RAB9A
SCHEMBL6222905 0.67 KDM4E (0.43) KDM4EALDH1A1GAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383768-B1 IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME (GB) 2006-09-06 EP disclosed
EP-1381606-B1 IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS MERCK SHARP & DOHME (GB) 2005-07-20 EP disclosed
US-6642229-B2 Treatment of adverse neurological conditions MERCK SHARP & DOHME LTD. 2003-11-04 US disclosed